•
Mar 31, 2024

PTC Therapeutics Q2 2024 Earnings Report

Total Revenue
$210M
Previous year: $214M
-1.7%
EPS
-$1.29
Previous year: -$1.48
-12.8%
Gross Profit
$144M
Previous year: $201M
-28.5%
Cash and Equivalents
$885M
Previous year: $208M
+324.6%
Free Cash Flow
$61.2M
Previous year: -$20.4M
-400.4%
Total Assets
$1.79B
Previous year: $1.34B
+33.7%

PTC Therapeutics

PTC Therapeutics